Revenue
$519.18M
Fiscal year ended 2026-06-30Operating income
$47.80M
Fiscal year ended 2026-06-30Free cash flow
$15.14M
Fiscal year ended 2026-06-30Core Laboratories Inc. /DE/ (CLB) reported revenue of $519.18M and net income of $24.35M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Core Laboratories Inc. /DE/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Oil & Gas Field Services, NEC.
Income
| Metric | 2026-06-30 |
|---|---|
| Revenue | $519.18M |
| Cost of revenue | $417.86M |
| Gross profit | $101.32M |
| Operating income | $47.80M |
| Net income | $24.35M |
| Research & development | Unavailable |
| Weighted-average diluted shares | Unavailable |
| Pretax income | $36.80M |
| Income tax expense | $12.10M |
| Diluted EPS | $0.52 |
| Selling, general & administrative | Unavailable |
| General & administrative | $46.99M |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-06-30 |
|---|---|
| Cash & equivalents | $22.74M |
| Total assets | $586.78M |
| Current assets | $214.36M |
| Total liabilities | Unavailable |
| Current liabilities | $101.05M |
| Total equity incl. NCI | $278.77M |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | $57.96M |
| Accounts receivable | $108.82M |
| Goodwill | $105.80M |
| Long-term debt | $113.86M |
| Accounts payable | $40.16M |
Cash flow
| Metric | 2026-06-30 |
|---|---|
| Operating cash flow | $28.22M |
| Capital expenditures | $13.08M |
| Investing cash flow | -$8.68M |
| Financing cash flow | -$27.99M |
| Net change in cash | Unavailable |
| Stock-based compensation | $8.37M |
| Common dividends paid | $1.85M |
| Common share repurchases | $14.35M |
| Depreciation & amortization | $14.85M |
Derived
| Metric | 2026-06-30 |
|---|---|
| Free cash flow | $15.14M |
| Gross margin | 19.5% |
| Operating margin | 9.2% |
| FCF margin | 2.9% |
| SBC / revenue | 1.6% |
| Current ratio | 2.12x |
| Revenue YoY growth | 0.3% |
| Net margin | 4.7% |
| R&D / revenue | Unavailable |
| CapEx / revenue | 2.5% |
| Long-term debt / equity | 0.41x |
| Effective tax rate | 32.9% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CLB in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-05-01View SEC filing
10-K · Filed 2026-03-23View SEC filing
10-Q · Filed 2025-10-23View SEC filing
10-Q · Filed 2025-07-25View SEC filing
10-Q · Filed 2025-04-28View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.